Want to join the conversation?
Pharma company $SUPN said a sixth patent has been issued by the United States Patent and Trademark Office on May 31 covering Oxtellar XR, a once-daily extended-release oxcarbazepine product. Oxtellar XR is an antiepileptic drug indicated for adjunctive therapy in treating partial seizures in adults and in children 6-17 years of age.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!